Atrás
Rango del Día
$58.96
$62.86
Rango de 52 Semanas
$32.00
$63.03
Volumen
158,222
Promedio 50D / 200D
$47.48
/
$47.48
Cierre Anterior
$58.89
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -82.0 | 0.4 |
| P/B | 39.7 | 2.9 |
| ROE % | -76.5 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$75.00
+21.1%
EPS Futuro
-$2.57
Ingresos Est.
0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
-$3.10
-$5.10 – -$1.60
|
49 M | 3 |
| FY2027 |
-$2.59
-$3.12 – -$2.00
|
10 M | 3 |
| FY2026 |
-$2.57
-$2.79 – -$2.35
|
0 | 2 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -23.69M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-76.46%
ROIC-36.74%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio11.77
Interest Coverage-45.77
Valoración
P/E Ratio
-82.00
P/B Ratio39.73
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -26.49M |
| ROE | -76.46% | ROA | -44.61% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -23.69M |
| ROIC | -36.74% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 11.77 |
| Interest Coverage | -45.77 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -82.00 | P/B Ratio | 39.73 |
| P/S Ratio | N/A | PEG Ratio | -4.04 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.17B | Enterprise Value | 2.12B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Income | -26.49M | -16.49M |
| EPS (Diluted) | -0.14 | -0.08 |
| Gross Profit | 0.0 | 0.0 |
| Operating Income | -26.78M | -17.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 |
|---|---|---|
| Total Assets | 59.38M | 18.46M |
| Total Liabilities | 4.72M | 3.84M |
| Shareholders' Equity | 54.67M | 14.62M |
| Total Debt | 0.0 | 786,000.0 |
| Cash & Equivalents | 53.08M | 16.30M |
| Current Assets | 55.54M | 17.56M |
| Current Liabilities | 4.72M | 3.05M |